Blog


Is Mandatory Participation in Medicare Demonstrations Necessary?

May 25, 2022

Recently, Health Affairs Forefront, published a post by Dan L. Crippen, former director of the Congressional Budget Office and currently a Healthcare Leaddership Council consultant, that should be a catalyst … Continued


Understanding State Laws for Interchangeable Biosimilars

October 15, 2021

An important development in the biopharmaceutical world, with significant ramifications for patients, is the progress being made on biosimilars.  These are products with the same safety and efficacy as FDA-approved … Continued


Technological Solutions for Vaccine Credentialing Critical to Nation’s Progress

September 20, 2021

Proof of COVID-19 vaccination has become, it’s an understatement to say, a political hot button issue across the country.  Nonetheless, as more private employers insist that their workforces be vaccinated … Continued


The Innovation-Competition-Affordability Connection and its Importance to Patients

June 15, 2021

One of the biggest headlines in healthcare this month occurred when the Food and Drug Administration gave approval to a new treatment for Alzheimer’s disease developed by Biogen. This is … Continued


Waiving Patent Protections for Vaccines is a Damaging and Short-Sighted Move

May 6, 2021

Biopharmaceutical companies are receiving justified praise for the rapid speed with which they produced effective vaccines against COVID-19, offering hope for a return to normalcy from a pandemic that has … Continued


An Innovation-Centric Approach to Pricing and Accessibility

July 7, 2016

“Policy should not lose sight of the fact that new treatments represent miracles to many patients, and should encourage more, not less innovation.” With those words in her op-ed in … Continued


The Trustees Report and the Need for Action

June 22, 2016

On a day in which the House Republicans are announcing their alternative health reform plan, House Democrats are staging a sit-in over gun laws, and the presumptive presidential nominees are … Continued


Utilizing Technology to Propel Precision Medicine Forward

April 4, 2016

As we’ve seen, there has been a steadily increasing level of discussion and enthusiasm surrounding precision medicine.  The Healthcare Leadership Council (HLC) has remained engaged in this conversation, given the … Continued


The Amazing, Classy, Winning (and Completely Ridiculous) $300 Billion Proposal

February 19, 2016

It’s a notion we’ve heard a fair amount during the presidential campaign, this idea that Medicare should ‘negotiate’ prescription drug prices.  (There’s a very good reason I put ‘negotiate’ in … Continued


Bringing Value to the Patient and the Healthcare System: A New Report

February 4, 2016

This week the Patient-Centered Primary Care Collaborative (PCPCC) unveiled its fifth annual report on the patient centered medical home’s (PCMH) impact on cost and quality.  In the quest to improve … Continued